Patrick B. Schwartz

1.3k total citations
31 papers, 414 citations indexed

About

Patrick B. Schwartz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Patrick B. Schwartz has authored 31 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Patrick B. Schwartz's work include Pancreatic and Hepatic Oncology Research (9 papers), Sarcoma Diagnosis and Treatment (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). Patrick B. Schwartz is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Sarcoma Diagnosis and Treatment (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). Patrick B. Schwartz collaborates with scholars based in United States, Switzerland and Pakistan. Patrick B. Schwartz's co-authors include Patricia Burkhardt‐Holm, Felix E. Wettstein, Thomas D. Bucheli, Karen L. Thorpe, Daniel E. Abbott, Christopher C. Stahl, Sean M. Ronnekleiv‐Kelly, Alexandra W. Acher, Taylor Aiken and Ryan C. Fields and has published in prestigious journals such as Gastroenterology, The Science of The Total Environment and Annals of Surgery.

In The Last Decade

Patrick B. Schwartz

30 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick B. Schwartz United States 12 90 80 80 69 45 31 414
Vikas Bhushan United States 8 30 0.3× 112 1.4× 91 1.1× 41 0.6× 64 1.4× 30 568
Qing Gu China 13 39 0.4× 56 0.7× 92 1.1× 161 2.3× 41 0.9× 21 619
Julien Yockell‐Lelièvre Canada 12 44 0.5× 52 0.7× 62 0.8× 23 0.3× 14 0.3× 21 816
Shengzhu Huang China 10 78 0.9× 26 0.3× 33 0.4× 33 0.5× 19 0.4× 27 497
Alí N. Kamali Iran 10 59 0.7× 40 0.5× 31 0.4× 20 0.3× 7 0.2× 22 508
Pan Su China 12 51 0.6× 51 0.6× 17 0.2× 31 0.4× 16 0.4× 27 414
Nicolas Collet France 8 26 0.3× 34 0.4× 79 1.0× 13 0.2× 19 0.4× 16 449
Louise Wang United States 9 91 1.0× 70 0.9× 47 0.6× 7 0.1× 24 0.5× 18 422
Xuechun Wang China 13 56 0.6× 22 0.3× 52 0.7× 8 0.1× 28 0.6× 43 489
Anna Koulova United States 9 22 0.2× 44 0.6× 39 0.5× 26 0.4× 69 1.5× 15 687

Countries citing papers authored by Patrick B. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Patrick B. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick B. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick B. Schwartz more than expected).

Fields of papers citing papers by Patrick B. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick B. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick B. Schwartz. The network helps show where Patrick B. Schwartz may publish in the future.

Co-authorship network of co-authors of Patrick B. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick B. Schwartz. A scholar is included among the top collaborators of Patrick B. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick B. Schwartz. Patrick B. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhaoting, Fanyi Mo, Kai Guo, et al.. (2024). Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer. Med. 5(4). 348–367.e7. 14 indexed citations
2.
Christensen, Leslie, et al.. (2024). Morbidity and Mortality Following Surgery for Pancreatic Cancer in Low‐ and Middle‐Income Countries: A Systematic Review and Meta‐Analysis. Journal of Surgical Oncology. 131(3). 435–442. 2 indexed citations
3.
Schwartz, Patrick B., Manabu Nukaya, Mark E. Berres, et al.. (2023). The circadian clock is disrupted in pancreatic cancer. PLoS Genetics. 19(6). e1010770–e1010770. 20 indexed citations
4.
Schwartz, Patrick B., et al.. (2023). Chronic jetlag accelerates pancreatic neoplasia in conditional Kras -mutant mice. Chronobiology International. 40(4). 417–437. 5 indexed citations
5.
McLean, Dalton, Jennifer J. Meudt, Dominic T. Schomberg, et al.. (2023). Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model. Frontiers in Oncology. 13. 1253659–1253659. 3 indexed citations
6.
Schwartz, Patrick B. & Daniel E. Abbott. (2022). ASO Author Reflections: An Opportunity to Provide Cost-Conscious Care for Patients Undergoing CRS-HIPEC. Annals of Surgical Oncology. 29(11). 6615–6616. 1 indexed citations
7.
Schwartz, Patrick B., Christopher C. Stahl, Glen Leverson, et al.. (2022). Rethinking Routine Intensive Care After Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy: The Fiscal Argument. Annals of Surgical Oncology. 29(11). 6606–6614. 3 indexed citations
8.
Collier, Amber L., Iago De Castro Silva, Deukwoo Kwon, et al.. (2022). Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium. Annals of Surgical Oncology. 30(3). 1485–1494. 5 indexed citations
9.
Acher, Alexandra W., Christopher C. Stahl, James R. Barrett, et al.. (2021). Clinical and Cost Profile of Controlled Grade B Postoperative Pancreatic Fistula: Rationale for Their Consideration as Low Risk. Journal of Gastrointestinal Surgery. 25(9). 2336–2343. 4 indexed citations
10.
Acher, Alexandra W., James R. Barrett, Patrick B. Schwartz, et al.. (2020). Early vs Late Readmissions in Pancreaticoduodenectomy Patients: Recognizing Comprehensive Episodic Cost to Help Guide Bundled Payment Plans and Hospital Resource Allocation. Journal of Gastrointestinal Surgery. 25(1). 178–185. 4 indexed citations
11.
Schwartz, Patrick B., Christopher C. Stahl, Cecilia G. Ethun, et al.. (2020). Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS‐NSQIP risk calculator. Journal of Surgical Oncology. 122(4). 795–802. 5 indexed citations
12.
Aiken, Taylor, James R. Barrett, Christopher C. Stahl, et al.. (2020). Operative Delay in Adults with Appendicitis: Time is Money. Journal of Surgical Research. 253. 232–237. 17 indexed citations
13.
Schwartz, Patrick B., George A. Poultsides, Kevin K. Roggin, et al.. (2020). PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. Journal of Surgical Research. 251. 228–238. 20 indexed citations
14.
Stahl, Christopher C., Patrick B. Schwartz, Taylor Aiken, et al.. (2020). Surgeon Variability Impacts Costs in Laparoscopic Cholecystectomy: the Volume-Cost Relationship. Journal of Gastrointestinal Surgery. 25(1). 195–200. 4 indexed citations
15.
Stahl, Christopher C., Patrick B. Schwartz, Cecilia G. Ethun, et al.. (2020). Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database. Annals of Surgical Oncology. 28(3). 1690–1696. 11 indexed citations
16.
Schwartz, Patrick B., Christopher C. Stahl, Courtney Pokrzywa, et al.. (2020). What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?. Annals of Surgical Oncology. 27(13). 4920–4928. 11 indexed citations
17.
Chouliaras, Konstantinos, Cecilia G. Ethun, George A. Poultsides, et al.. (2019). Role of radiation therapy for retroperitoneal sarcomas: An eight‐institution study from the US Sarcoma Collaborative. Journal of Surgical Oncology. 120(7). 1227–1234. 26 indexed citations
18.
Schwartz, Patrick B., et al.. (2011). Embryotoxic and genotoxic potential of sewage system biofilm and river sediment in the catchment area of a sewage treatment plant in Switzerland. Ecotoxicology and Environmental Safety. 74(5). 1271–1279. 13 indexed citations
19.
Schwartz, Patrick B., Thomas D. Bucheli, Felix E. Wettstein, & Patricia Burkhardt‐Holm. (2011). Life‐cycle exposure to the estrogenic mycotoxin zearalenone affects zebrafish (Danio rerio) development and reproduction. Environmental Toxicology. 28(5). 276–289. 33 indexed citations
20.
Solga, Steven F., Keary A. Cope, Jeanne M. Clark, et al.. (2006). Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations. Biomarkers. 11(2). 174–183. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026